28 January 2025
Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP GSK plc (LSE/NYSE: GSK) today announced…
HENRY BOOT PLC (‘Henry Boot’ or ‘the group’) TRADING UPDATE FOR THE YEAR ENDED 31 DECEMBER 2024 Henry Boot, a company engaged in land…
Harworth Group plc (“Harworth” or “the Group”) Trading Update Strong operational performance and record land sales driving NDV growth Harworth, a leading regenerator of…
Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more…
Dotdigital Group plc (“Dotdigital”, the ” Company”, or the “Group”) Trading Update & Notice of Half Year Results Positive momentum underpinned by enhanced product offering…
27 January 2025
27 January 2025 Smithson Investment Trust plc (the “Company”) Publication of Investment Manager’s review The Company has today published a letter to shareholders from the…
27 January 2025 Concurrent Technologies Plc (the “Company” or the “Group”) Major VME Product Order from Long-Term European Customer Secured Validating Concurrent’s strategy of…
GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research collaboration focused on the potential…